An Open-Label Randomized, Multicenter, Phase IIIB Study To Assess the Efficacy, Safety, and Tolerance of Beriplex P/N Compared with Plasma for the Rapid Reversal of Coagulopathy Induced by Coumadin Derivatives in Subjects Requiring Emergency Surgery or Invasive Intervention.

Grants and Contracts Details

StatusNot started